📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis. (2023)

First Author: John BV
Attributed to:  Regenerative medicine applications of cholangiocyte organoids funded by UKRI FLF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/joim.13630

PubMed Identifier: 37018129

Publication URI: http://europepmc.org/abstract/MED/37018129

Type: Journal Article/Review

Volume: 293

Parent Publication: Journal of internal medicine

Issue: 5

ISSN: 0954-6820